id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2006-P-0145-0006,FDA,FDA-2006-P-0145,"Attachment 3 - Draft Insert Labeling Proposed for Propoxyphene Hydrochloride, 65 mg and Acetaminophen, 325 mg Tablets",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2008-11-17T05:00:00Z,2008,11,,,2024-12-10T14:46:59Z,,0,0,090000648045049b
FDA-2006-P-0145-0007,FDA,FDA-2006-P-0145,"Attachment 1 - Approved Drug Products with Therapeutic Equivalence Evaluations, Electronic Orange Book listing accessed December 12, 2006",Supporting & Related Material,Background Material,2008-11-17T05:00:00Z,2008,11,,,2024-12-10T14:49:24Z,,0,0,090000648045049c
FDA-2006-P-0145-0003,FDA,FDA-2006-P-0145,"Citizen Petition from Lachman Consultant Services, Inc.",Other,Citizen Petition,2008-11-17T05:00:00Z,2008,11,2008-11-17T05:00:00Z,,2024-12-10T13:56:55Z,,0,0,090000648045049e
FDA-2006-P-0145-0004,FDA,FDA-2006-P-0145,"Attachment 2 - Labeling for reference-listed drug product (RLD), Wygesic Tablets (Leitner)",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2008-11-17T05:00:00Z,2008,11,,,2024-12-10T14:26:07Z,,0,0,0900006480450498
FDA-2006-P-0145-0005,FDA,FDA-2006-P-0145,Attachment 4 - List of products approved in Electronic Orange Book with 325 mg dosage strength of Acetaminophen,Supporting & Related Material,Background Material,2008-11-17T05:00:00Z,2008,11,,,2024-12-10T14:32:52Z,,0,0,090000648045049a